HOMEPAGE
Fully Diluted Subscribe

NYSE · Biotech stocks database

ABT — Abbott Laboratories

ABT (Abbott Laboratories) stock: $109.96, $190.44B market cap, $4.30B cash, $217.31B EV, $193.81B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

DEVELOPMENT OF BUSINESS Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott’s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market.

Source: 10-K FY2025 via SEC EDGAR

Share price
$109.96
Market cap
$190,444.3M
Cash
$4,298.0M
Enterprise value
$217,305.3M

Balance sheet

Cash$4,298.0M
Debt$31,159.0M
Net cash-$26,861.0M
Enterprise value$217,305.3M
Basic shares1,731.9M shares
Fully diluted shares1,762.5M shares
Fully diluted market cap$193,806.1M
Cash per share$2.48
Quarterly burn+$1,503.1M generated

Cash figures as of 2026-09-30. Database snapshot: 2026-11-07.

Share structure

Common
1,730.4M
Pre-funded warrants
—
Options
22.6M
RSUs
9.5M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
1,762.5M

Cap table as of 2026-03-31.

Price history

Loading ABT daily closes…

Loading price history…

Next catalyst

Oral Anticoagulant, Direct-Acting · Aug 18 - Sep 29 in 58 mo · Phase 3 · Cryptogenic Ischemic Stroke; Patent Foramen Ovale

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego